ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Wassim Fares, MD
Mannkind Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
99 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Macquarie University Clinical Trials Unit
Sydney, New South Wales, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- the Prince Charles Hospital
Brisbane, Queensland, Australia
- Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
- Monash University Centre for Inflammatory Diseases
Cranbourne, Victoria, Australia
- Alfred Health
Melbourne, Victoria, Australia
- Royal Perth Hospital Respiratory Clinic
Perth, Western Australia, Australia
- Royal Adelaide Hospital
Adelaide, Australia
- Concord Repatriation General Hospital
Concord, Australia
- Aso Iizuka Hospital
Fukuoka, Japan
- Fukuoka University Chikushi Hospital
Fukuoka, Japan
- Fukuoka University Hospital
Fukuoka, Japan
- National Hospital Organization Fukuokahigashi Medical Center
Fukuoka, Japan
- National Hospital Organization Omuta National Hospital
Fukuoka, Japan
- National Hospital Organization Shibukawa Medical Center
Gunma, Japan
- Himeji Medical Center
Hyōgo, Japan
- Ibarakihigashi National Hospital
Ibaraki, Japan
- Kameda Clinic
Kamogawa-shi, Japan
- Showa University Fujigaoka Hospital
Kanagawa, Japan
- Minami Kyoto Hospital
Kyoto, Japan
- Matsusaka Municipal Hospital
Matsusaka, Japan
- Sendai Kousei Hospital
Miyagi, Japan
- Nishiniigata Chuo Hospital
Niigata, Japan
- National Hospital Organization - Osaka Toneyama Medical Center
Osaka, Japan
- Saitama Prefectural Cardiovascular and Respiratory Center
Saitama, Japan
- National Hospital Organization Kinki-Chuo Chest Medical Center
Sakai, Japan
- Keio University Hospital
Shinjuku-ku, Japan
- National Hospital Organization Tenryu Hospital
Shizuoka, Japan
- Center Hospital of the National Center for Global Health and Medicine
Tokyo, Japan
- Japan Anti-Tuberculosis Association Fukujuji Hospital
Tokyo, Japan
- Japanese Red Cross Musashino Hospital
Tokyo, Japan
- Mutual Aid Associations Toranomon Hospital
Tokyo, Japan
- Toho University Omori Medical Center
Tokyo, Japan
- Showa University Northern Yokohama Hospital
Yokohama, Japan
- Chonnam National University Hospital
Gwangju, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- the Catholic University of Korea Seoul St.Mary'S Hospital
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2024
- Primary completion
- 10 Nov 2025
- Completion
- 10 Nov 2025
- Last update posted
- 12 Nov 2025
- Registered enrollment
- 132
- Registry id
- NCT06418711
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.